Short Interest in Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Expands By 91.7%

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 65,000 shares, an increase of 91.7% from the January 15th total of 33,900 shares. Based on an average daily trading volume, of 471,700 shares, the days-to-cover ratio is currently 0.1 days.

Daiichi Sankyo Price Performance

Shares of DSNKY stock traded down $0.56 on Friday, hitting $23.89. 199,873 shares of the company’s stock were exchanged, compared to its average volume of 213,522. Daiichi Sankyo has a 12 month low of $22.80 and a 12 month high of $42.48. The stock has a market cap of $45.59 billion and a P/E ratio of 26.73. The company has a 50 day moving average of $27.21 and a 200 day moving average of $32.11.

Daiichi Sankyo (OTCMKTS:DSNKY) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.22 earnings per share for the quarter. Sell-side analysts predict that Daiichi Sankyo will post 0.82 EPS for the current fiscal year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.